Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-30

Clinical Trial Update: Varenicline Treatment for Active Alcoholic Smokers [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating varenicline for active alcoholic smokers has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: Mayo Clinic | Conditions: Smoking, Tobacco Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-05-30